artemether has been researched along with Alloxan Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y; Chen, Y; Ge, N; Gu, X; Han, P; Huang, J; Rong, G; Shao, M; Sun, H; Weng, W; Wu, X; Yu, X; Yuan, R | 1 |
| Charlotte Moffett, R; Flatt, PR; Irwin, N; Lafferty, RA; Sarnobat, D; Tarasov, AI | 1 |
| Bai, X; Lei, W; Pei, R; Shang, J; Tian, L; Zhang, J; Zhao, M | 1 |
3 other study(ies) available for artemether and Alloxan Diabetes
| Article | Year |
|---|---|
Artemether Alleviates Diabetic Kidney Disease by Modulating Amino Acid Metabolism.
Topics: Amino Acids; Animals; Artemether; Chromatography, Liquid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Kidney; Mice; Tandem Mass Spectrometry | 2022 |
Effects of artemether on pancreatic islet morphology, islet cell turnover and α-cell transdifferentiation in insulin-deficient GluCreERT2;ROSA26-eYFP diabetic mice.
Topics: Animals; Artemether; Blood Glucose; Cell Transdifferentiation; Diabetes Mellitus, Experimental; Glucagon; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Mice; Streptozocin | 2022 |
Antidiabetic Effect of Artemether in Db/Db Mice Involves Regulation of AMPK and PI3K/Akt Pathways.
Topics: AMP-Activated Protein Kinases; Animals; Artemether; Blood Glucose; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Random Allocation; Signal Transduction | 2020 |